Fresenius Boosts Junk Bond Offering With Yields at 5-Month Low
This article is for subscribers only.
Fresenius Medical Care AG, the world’s biggest provider of kidney dialysis, sold $1.5 billion of speculative-grade debt in a boosted offering as yields on such securities drop to a five-month low.
The company issued $800 million of 5.625 percent notes due July 2019 and $700 million of 5.875 percent debt due January 2022, up from a planned $1.2 billion sale, said a person with knowledge of the transaction. European companies from Ardagh Packaging Finance Plc to Welltec A/S are also marketing high-yield debt in dollars, said another person, who declined to be identified because terms aren’t set.